
HHS SEC ROBERT F KENNEDY JR: American patients pay more so others can pay less — that stops now
Fox News
President Donald Trump's drug pricing order seeks to balance innovation with affordability, ending the burden on American patients and ensuring fair global contributions.
Robert F. Kennedy Jr. is the 26th Secretary of the U.S. Department of Health and Human Services.
Industry leaders recognize this imbalance. I've already engaged with CEOs from four major American pharmaceutical companies and a foreign manufacturer eager to relocate to the U.S. Their response has been encouraging, but we're prepared to act decisively if necessary. U.S. Health and Human Services and Centers for Medicare & Medicaid Services (CMS) possess the statutory authority to deliver on President Trump’s commitment: other developed nations must pay more, so Americans can pay less, thus preserving the innovation pipeline.













